Today: 20 March 2026
Browse Category

NYSE:ABEV 24 October 2025 - 19 March 2026

Ambev Stock Falls as Brazil Freight Crackdown Revives Cost Risk

Ambev Stock Falls as Brazil Freight Crackdown Revives Cost Risk

Ambev’s U.S. shares fell 0.9% after Brazil’s government fined the brewer for violating minimum freight-price rules and warned repeat offenders could lose freight hiring rights. The Ministry of Transport reported 419 million reais in fines over four months and a sharp rise in monthly citations. Ambev’s Q4 organic volume dropped 3.6%, and the company expects Brazil beer production costs to rise up to 7.5% in 2026.
19 March 2026
Ambev Stock Price Today: ABEV3 Near R$15 as Neutral Call Flags Limited 2026 Upside

Ambev Stock Price Today: ABEV3 Near R$15 as Neutral Call Flags Limited 2026 Upside

Ambev shares closed at 14.93 reais in Sao Paulo Thursday, while New York ADRs fell 4.3% to $2.86 after BB Investimentos maintained a neutral rating and a 16-real target. Full-year 2025 normalized EBITDA rose 5.6% with a margin increase, but fourth-quarter profit dropped 8% and volumes slid 3.6%. The board set April 6 for a 1.2 billion-real payout. Broker sentiment remains mostly neutral.
12 March 2026
Ambev S.A. (NYSE: ABEV) Stock News: Latest Headlines, Analyst Price Targets, Dividends, and What to Watch Before Monday’s Open

Ambev S.A. (NYSE: ABEV) Stock News: Latest Headlines, Analyst Price Targets, Dividends, and What to Watch Before Monday’s Open

Ambev S.A. ADR (NYSE: ABEV) closed at $2.43 on Friday, Dec. 26, up 2.5%, with about 31 million shares traded. The stock rebounded late in the week after a sharp drop on Dec. 22. No new corporate filings or earnings were released over the weekend as U.S. markets remained closed. Recent analyst notes maintained a Hold rating and a $2.50 price target.
28 December 2025
Ambev Stock (NYSE: ABEV) Weekend Watch: Options Volatility Signals a Potential Move as Analysts Debate Valuation Ahead of the Next Session

Ambev Stock (NYSE: ABEV) Weekend Watch: Options Volatility Signals a Potential Move as Analysts Debate Valuation Ahead of the Next Session

Ambev S.A. closed Friday at $2.43, gaining 2.53% with about 30.8 million shares traded. Options activity shows elevated implied volatility, signaling traders expect a larger move ahead. Analysts remain divided on valuation, with price targets clustering near $2.53 and consensus estimates for the current quarter slipping from $0.06 to $0.05. No major company announcements in the past two days.
28 December 2025
Ambev Stock (ABEV) News and Forecasts: Dividend & Interest Payouts, Buyback Plans, and Analyst Targets as of Dec. 24, 2025

Ambev Stock (ABEV) News and Forecasts: Dividend & Interest Payouts, Buyback Plans, and Analyst Targets as of Dec. 24, 2025

Ambev ADRs traded near $2.37 on Dec. 24, 2025, after the company declared a dividend of R$0.4612 per share and a gross “interest on capital” payout of R$0.2690 per share. Shares moved on heavy volume as investors positioned ahead of the Dec. 30 payout. The stock traded ex-dividend around these dates. Institutional activity increased, with Exchange Traded Concepts reported as a buyer.
24 December 2025
Ambev Stock Price Today (ABEV): Latest News, Dividend Details, and 2026 Analyst Forecasts — December 23, 2025

Ambev Stock Price Today (ABEV): Latest News, Dividend Details, and 2026 Analyst Forecasts — December 23, 2025

Ambev shares fell over 7% on Dec. 22, marking their steepest one-day drop since December 2024, before stabilizing Tuesday near $2.36. The move followed the company’s announcement of a R$0.4612 per share cash dividend payable Dec. 30 in Brazil and approval of R$0.2690 per share interest on own capital to be paid by end-2026. U.S. ADR holders are set to receive about $0.0841 per ADR in January.
23 December 2025
Ambev S.A. Stock (ABEV) on Dec. 19, 2025: Dividend Timeline, Buyback Plans, Analyst Calls, and What Comes Next

Ambev S.A. Stock (ABEV) on Dec. 19, 2025: Dividend Timeline, Buyback Plans, Analyst Calls, and What Comes Next

Ambev shares traded at $2.48 in New York on Dec. 19, down 1.6% after the company’s stock went ex-dividend and ex-interest on equity. The board approved a dividend of R$0.4612 per share, payable Dec. 30, and gross IOC of R$0.2690 per share, with payment by end-2026. A buyback of up to 208 million shares is authorized. Q3 volumes fell, but profit rose.
19 December 2025
Ambev (ABEV) Stock News Today: Dividend Boost, New Capacity, and 2026 Forecasts in Focus (Dec. 17, 2025)

Ambev (ABEV) Stock News Today: Dividend Boost, New Capacity, and 2026 Forecasts in Focus (Dec. 17, 2025)

Ambev’s board approved dividends of R$0.4612 per share, payable Dec. 30, 2025, and interest on own capital of R$0.2690 gross per share, to be paid by Dec. 31, 2026. The NYSE ADR trades ex-dividend and ex-IOC starting Dec. 19. Ambev’s ADR closed at $2.55 on Dec. 16, near its 52-week high. The company is also expanding premium beer output and packaging capacity.
Ambev (ABEV) Stock Today, November 26, 2025: Bernstein Downgrade Caps a Strong Rally Near 52‑Week Highs

Ambev (ABEV) Stock Today, November 26, 2025: Bernstein Downgrade Caps a Strong Rally Near 52‑Week Highs

Ambev’s U.S.-listed ADR traded at $2.52 Wednesday afternoon, up slightly from Tuesday, after Bernstein downgraded the stock to “Market Perform” and set a $2.88 price target. The downgrade follows a 30–40% year-to-date rally, with shares near a 52-week high. Trading volume was heavy as investors reacted to the news. On Brazil’s B3, Ambev shares slipped 0.4% to R$13.68.
26 November 2025
Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev’s Profit Soars 36% in Q3 – Buyback Announced as ABEV Stock Eyes Rally

Ambev S.A. reported Q3 net income of 4.86 billion reais, up 36% year-on-year and well above analyst forecasts. Beer volumes fell 5.9%, but higher prices kept revenue flat; EBITDA was R$7.06 billion, beating estimates. The board approved a buyback of up to 208 million shares. Shares traded around $2.25 after results, with analysts split on outlook amid sector headwinds.

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop